4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0002036798-26-000002
Options or other derivatives
- President and CEO acquired 890,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| ALEXANDER MARGARET A. President and CEO | 2026-01-04 | Grant or award · Employee Stock Option (right to buy) | +890,000 | 890,000 | D | ||
Loading xslF345X05/form4-01052026_050101.xml…